Vernal Biosciences
Colchester, US · Founded 2020 · 3 known investors
Find your way into Vernal Biosciences
208 people in our graph share verified history with the Vernal Biosciences team — schools, employers, funds. One of them is your warm intro.
Bill Pescatellounlockedknows Christian Cobaugh · together at Northwestern University (overlapped)
×2knows the team · via Northwestern University
knows the team · via Omega Therapeutics
×7knows the team · via The University of Texas at Austin
knows the team · via CRISPR
Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development. The company serves researchers and biotech companies seeking reliable mRNA supply for drug discovery and clinical applications.
Founders & leadership
Vernal Biosciences was founded in 2020 by Christian Cobaugh.
CC
Christian CobaughinChief Scientific Officer and Founder2024–2025He has extensive experience in LNP-mRNA process technologies, manufacturing, and regulatory matters, with a background in pre-clinical research, drug discovery, and advancing therapeutic programs from early-stage development to clinical applications across multiple modalities including gene editing, RNA, and protein therapeutics.
Board
EA
Errik AndersonBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$42.5M disclosed across 2 rounds · 2021–2022
▶$41MraisedJun 2023 · 10 investors · BiotechnologyRule 506(b)
▶$41MraisedJun 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David AndersonDirector
- Daniella KranjacDirector
- Christian CobaughExecutive Officer, Director
- Offering amount
- $41M
- Amount sold
- $41M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.5MraisedMay 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christian CobaughExecutive Officer, Director
- Errik AndersonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Vernal Biosciences do?
- Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development. The company serves researchers and biotech companies seeking reliable mRNA supply for drug discovery and clinical applications.
- Who founded Vernal Biosciences?
- Vernal Biosciences was founded by Christian Cobaugh in 2020.
- Who are Vernal Biosciences's investors?
- Vernal Biosciences's investors include Dynamk Capital, Ampersand, Avant Bio.
- How much funding has Vernal Biosciences raised?
- Vernal Biosciences has disclosed $42.5M raised across 2 rounds.
- Where is Vernal Biosciences headquartered?
- Vernal Biosciences is headquartered in Colchester, US.